Enova International, Inc. vs S&P Global Inc., two Credit Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
The multiples price two unrelated models: Enova at 18.8 times earnings for online-lending expansion, S&P Global at 25.8 for data-and-ratings compounding. S&P earns the far better margins, 30.4% net against 9.95%, and on assets 7.9% against 4.75%, the toll booth's economics beating the lender's, though Enova wins on equity, 23.3% against 15.3%, on its leverage. S&P carries 0.51 turns of debt against Enova's 3.45, and pays a 0.9% dividend. Enova takes credit risk for its returns while S&P takes none for its margins, and the market pays a premium for the risk-free recurring revenue over the leveraged loan book.
Comparison updated 2026-07-11.
| Metric | ENVA | SPGI |
|---|---|---|
| Price | $230.90 | $408.17 |
| Market cap | $6.1B | $121.5B |
| Sector | Financial Services | Financial Services |
| Stage | Growth | Mature |
| Implied growth (priced in) | +1.2% | +14.6% |
| P/E | 18.8 | 25.8 |
| P/B | 4.34 | 3.88 |
| P/S | 1.85 | 7.72 |
| EV/EBITDA | 13.3 | 16.8 |
| Revenue growth | +17.6% | +8.5% |
| Gross margin | 60.4% | — |
| Operating margin | 23.7% | 48.0% |
| Net margin | 9.9% | 30.4% |
| Return on equity | 23.3% | 15.3% |
| Return on assets | 4.8% | 7.9% |
| Dividend yield | 1.6% | 0.9% |
| Debt / equity | 3.45 | 0.51 |
| Current ratio | — | 0.68 |
| Altman Z (solvency) | 1.67 | 3.84 |
| Piotroski F (quality) | 7 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.